Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)
Last verified by NonDilute: 2026-06-08. Official notice and agency instructions control.
If your institution trains early-career researchers in AD/ADRD translational science, this T32 funds a structured multi-year program to formalize and expand that pipeline.
Report stale or inaccurate summary
What this is
The National Institutes of Health is seeking eligible institutions to establish or expand institutional training programs that prepare early-career researchers (predoctoral and postdoctoral trainees) for careers in Alzheimer's disease and ADRD research. Programs must be interdisciplinary, combining training in data science, disease biology, behavioral research, and drug discovery to enable rigorous basic, translational, and clinical research. This is a workforce-development grant, not project-specific funding, and clinical trials are not allowed. The funding period runs through September 2026.
Who can apply
Eligible applicants include public and private institutions of higher education, nonprofits with or without 501(c)(3) status, small businesses, state and local governments, and Native American tribal organizations. Solo founders and independent researchers are not eligible; the applicant must be an institution capable of hosting an organized training program for multiple trainees.
Eligible applicant types
- Native American tribal organizations (other than Federally recognized tribal governments)
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Special district governments
- Public and State controlled institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- State governments
- Small businesses
- Independent school districts
- Public housing authorities/Indian housing authorities
- County governments
- City or township governments
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- For profit organizations other than small businesses
- Native American tribal governments (Federally recognized)
Full description — from the agency
The specific purpose of this Notice of Funding Opportunity (NOFO) is to promote the development of a diverse, interdisciplinary workforce needed to conduct translational research on Alzheimer's disease and Alzheimer's-related dementias from target discovery through clinical development. This NOFO will support institutional training programs for predoctoral and postdoctoral level researchers with diverse educational backgrounds (i.e., basic biology, translational and clinical research, data science). The program invites eligible institutions to develop interdisciplinary training programs that will provide trainees with the knowledge and skills in data science, disease biology, behavioral research, and traditional and emerging drug discovery disciplines necessary to conduct rigorous and cutting-edge basic, translational, and clinical research for AD/ADRD.
Topics: alzheimer's disease training · translational research workforce · predoctoral postdoctoral programs · interdisciplinary neuroscience training · T32 institutional training grant · drug discovery education · data science neuroscience
Public-source funding discovery only. This summary is generated from public agency data and may be incomplete or stale. NonDilute is not affiliated with, endorsed by, or acting on behalf of any government agency. Official notices and agency instructions control. NonDilute does not determine eligibility, provide grant-writing advice, or guarantee funding.